Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
9(64%)
Results Posted
0%(0 trials)

Phase Distribution

Ph early_phase_1
1
7%
Ph phase_3
4
29%
Ph phase_4
8
57%

Phase Distribution

1

Early Stage

0

Mid Stage

12

Late Stage

Phase Distribution13 total trials
Early Phase 1First-in-human
1(7.7%)
Phase 3Large-scale testing
4(30.8%)
Phase 4Post-market surveillance
8(61.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

9

trials recruiting

Total Trials

14

all time

Status Distribution
Active(10)
Completed(2)
Other(2)

Detailed Status

Recruiting9
Completed2
unknown2
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
14
Active
9
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (7.7%)
Phase 34 (30.8%)
Phase 48 (61.5%)

Trials by Status

recruiting964%
completed214%
not_yet_recruiting17%
unknown214%

Recent Activity

9 active trials
Showing 5 of 14
recruitingphase_3

Multi-center Trial of Ferric Derisomaltose in Children 0 to <18 Years of Age With Iron Deficiency Anemia

NCT05179226
recruitingphase_4

The Effects of Intravenous Iron on Mobility in Elderly Patients Following Hip Fracture Surgery

NCT06898814
not_yet_recruitingphase_4

Postoperative Intravenous Ferric Derisomaltose for Prevention of Long-term Anemia After Cardiac Surgery

NCT07238972
recruitingphase_3

Multi-center Trial of Ferric Derisomaltose Versus no Intravenous Iron in Iron-deficient Subjects With Symptomatic Chronic Heart Failure

NCT06929806
recruitingphase_4

The Effects of Ferric Derisomaltose on Postoperative Anemia in Spinal Deformity Surgery

NCT05714007
View all 14 trials

Clinical Trials (14)

Showing 14 of 14 trials
NCT05179226Phase 3

Multi-center Trial of Ferric Derisomaltose in Children 0 to <18 Years of Age With Iron Deficiency Anemia

Recruiting
NCT06898814Phase 4

The Effects of Intravenous Iron on Mobility in Elderly Patients Following Hip Fracture Surgery

Recruiting
NCT07238972Phase 4

Postoperative Intravenous Ferric Derisomaltose for Prevention of Long-term Anemia After Cardiac Surgery

Not Yet Recruiting
NCT06929806Phase 3

Multi-center Trial of Ferric Derisomaltose Versus no Intravenous Iron in Iron-deficient Subjects With Symptomatic Chronic Heart Failure

Recruiting
NCT05714007Phase 4

The Effects of Ferric Derisomaltose on Postoperative Anemia in Spinal Deformity Surgery

Recruiting
NCT05462704Phase 3

Intravenous Versus Oral Iron for Treating Iron-Deficiency Anemia in Pregnancy

Recruiting
NCT05407987Phase 3

Ferric Derisomaltose and Outcomes in the Recovery of Gynecologic Oncology: ERAS (Enhanced Recovery After Surgery)

Recruiting
NCT05929729Phase 4

Iron Deficiency Anemia (IDA) and the Brain

Recruiting
NCT05763043Early Phase 1

Monoferric for Prenatal Iron Deficiency

Recruiting
NCT06542822

IRONHEART: Intravenous Iron in Non-ischaemic Heart Failure

Recruiting
NCT05991128Phase 4

The Effects of Ferric Derisomaltose in Patients With Acute Heart Failure and Iron Deficiency on Exercise Capacity and Quality of Life

Unknown
NCT05971732Phase 4

The Effects of Ferric Derisomaltose in Patients With Acute Heart Failure and Iron Deficiency on Exercise Capacity and Quality of Life(COREVIVE-HFrEF)

Unknown
NCT04608539Phase 4

A Clinical Trial Assessing the Efficacy of Intravenous Iron for the Treatment of Anemia Following Cardiac Surgery

Completed
NCT02642562Phase 4

Intravenous Iron Treatment in Patients With Heart Failure and Iron Deficiency: IRONMAN

Completed

All 14 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
14